<strike id="1rpfh"><dl id="1rpfh"><del id="1rpfh"></del></dl></strike>
<span id="1rpfh"><dl id="1rpfh"><strike id="1rpfh"></strike></dl></span>
<strike id="1rpfh"></strike>
<strike id="1rpfh"><dl id="1rpfh"></dl></strike>
<ruby id="1rpfh"><dl id="1rpfh"><del id="1rpfh"></del></dl></ruby>

About Us

We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.

Female patient about to receive treatment

Working Together For Patients

Patients are at the center of everything we do.

About Bristol-Myers Squibb Ireland

Bristol-Myers Squibb has been in Ireland for over 50 years, and today we offer career opportunities across multiple functions, including Biologics Manufacturing, External Manufacturing and Commercial.

BMS first began operations in Ireland in 1964 with an Active Pharmaceutical Ingredient Plant (API) in Swords, County Dublin. The current BMS operations in Ireland include a newly constructed state-of-the-art biologics drug-substance manufacturing facility in Cruiserath, Dublin 15 and External Manufacturing divisions in Blanchardstown, Dublin 15 and Shannon, Co. Clare. BMS Ireland employs approximately 650 people.?


The BMS Cruiserath facility is a Multi-Product Cell Culture Biologics Manufacturing facility part of the Global Product Development and Supply (GPS) within the BMS network. The new state of the art facility will produce multiple therapies for the company’s growing biologics portfolio.


The Multi-Product Cell Culture Facility holds six 15,000 litre bioreactors. The facility will initially manufacture a single product at a time and eventually move to between three to five campaigns per year. The facility is highly flexible, designed to accommodate a variety of cell culture processes.

The Global Biologics Laboratory is located on the Cruiserath site. The Global Biologics Laboratory is responsible for the release testing of Biologics Drug product for the BMS network.

BMS Cruiserath Biologics is certified as a Great Place to Work for 2017 and recognised as a Best Large Workplace in Ireland.?


Travelling to Cruiserath – Bristol-Myers Squibb Cruiserath, Cruiserath Drive Mulhuddart, Dublin 15.?



External Manufacturing

BMS has two External Manufacturing sites based in Dublin 15 and Shannon, Co. Clare. The External Manufacturing network is responsible for the management of third party drug manufacturing operations.


Our robust operating model is focused on evolving and continuously improving our ways of working to take External Manufacturing to the next level, leveraging data and technology in an effort to deliver product to our customers and patients at optimum speed and cost.


Travelling to External Manufacturing Dublin – Plaza 254 Blanchardstown Corporate Park 2, Ballycoolin, Dublin 15



Our Company

Our Bristol-Myers Squibb values and principles commit us to the highest standard of moral and ethical behavior and affirms our conviction that "the priceless ingredient of every product is the honor and integrity of its maker."

Diversity & Inclusion

Our workforce is globally diverse to create an inclusive, high-performance culture that is agile, entrepreneurial, and accountable.


It's about doing the right thing for the patients we serve around the world. We take action on many fronts to reduce health disparities and improve outcomes in communities that are disproportionately affected by serious diseases.

Bristol-Myers Squibb Foundation

The Bristol-Myers Squibb Foundation?promotes health equity and seeks to improve the health outcomes of populations disproportionately affected by serious diseases. The Bristol-Myers Squibb Foundation has a number of Global Initiatives & Programs.

Discover our Culture?

To meet our mission of helping patients to prevail over serious diseases, Bristol-Myers Squibb Ireland are committed to developing a 21st century workplace culture that empowers, engages and enriches employees to discover and develop important new medicines for patients around the world.

Approval number: NOIE2003264
Date: May 2020